Share on LinkedInShare on LinkedIn

ARTICLE · 16 DECEMBER 2010

December Antitrust Bulletin

On Dec. 1, 2010, the Federal Trade Commission (FTC) challenged Laboratory Corp. of America's $57.5 million acquisition of Westcliff Medical Laboratories Inc., a rival clinical laboratory testing company, alleging that the transaction would harm competition in Southern California.

United StatesAntitrust/Competition Law

FTC Challenges Consummated Merger Approved by Bankruptcy Court

On Dec. 1, 2010, the Federal Trade Commission (FTC) challenged Laboratory Corp. of America's $57.5 million acquisition of Westcliff Medical Laboratories Inc., a rival clinical laboratory testing company, alleging that the transaction would harm competition in Southern California. The FTC brought this action even though the transaction had been approved by the bankruptcy court in connection with Westcliff's Chapter 11 proceedings. The case is the latest in a series of challenges to consummated mergers by the federal antitrust agencies, and serves as a reminder that even bankruptcy court approval will not prevent antitrust scrutiny of a transaction.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from